IMPORTANT EU Project
@IMPORTANTrial
Followers
45
Following
33
Media
8
Statuses
75
IMPORTANT has received funding from @HorizonEU Research and Innovation actions supporting the implementation of the Mission on #Cancer #BreastCancer #Trial
Europe
Joined September 2023
Our project was represented at the EU Health Policy Platform Live Webinar, where Coordinator Antonis Valachis joined Panel Session 1 on Treatment Optimisation. Proud to contribute to advancing cancer diagnosis & treatment across Europe #HorizonEurope @IMPORTANTrialC
0
0
0
Our project was proudly represented at #ESMO25 where Prof. Laura Biganzoli presented details of our trial on geriatric assessment for CDK4/6 inhibitor dose optimisation in older breast cancer patients @IMPORTANTrialC #IMPORTANTtrial #HorizonEurope #BreastCancer #ClinicalResearch
0
0
0
🆕December issue now online: 👉2025 St Gallen International Breast Cancer Consensus Statement 👉@myESMO guidance on the use of Large Language Models in Clinical Practice 👉A-BRAVE: a ph III RCT with anti-PD-L1 avelumab in high-risk TNBC patients https://t.co/YxmhZWD6Ar
2
4
16
Join Victoria Mapplebeck alongside Fruitfly Collective and @SaskiaBaron for a Q&A discussing the impact of cancer on families and getting a first look at acclaimed film ‘Mother Board’. Find out more: https://t.co/fbQv8o9SWk
0
2
0
“Moving Forward helped me to feel less alone.” - Katy Each £1 raffle ticket could help us fund Moving Forward, you’ll also have a chance to win our £10,000 jackpot!* *T&Cs apply. https://t.co/cVJg6kvpzc
1
3
4
📣 Late-breaking abstracts for ESMO Asia 2025 are live! Discover cutting-edge research and key updates driving progress in oncology. 👉 Check out the newest data now. #ESMOAsia25 #esmomeetings 🔗 https://t.co/rmti7GyqtE
0
6
12
Our project joined the 2nd #HorizonEurope Cancer Mission “Diagnosis & Treatment” Cluster Meeting in Berlin 🇩🇪 We shared actions on #CitizenEngagement #AddressingInequalities in cancer care highlighting how we bring science closer to people #CancerResearch
https://t.co/MiqUsKYuxe
0
1
1
Eunomia Ltd in collaboration with the European University Cyprus,School of Medicine, participates in the European Researchers Night in Nicosia,Cyprus We are also sharing updates on the @IMPORTANTrial 📍Don’t forget to visit our booth #EuropeanResearchersNight #Breastcancer
0
2
4
#ESMO25: Overall survival was significantly improved with zanzalintinib, a multitargeted #TKI, plus atezolizumab vs regorafenib in patients with previously treated metastatic colorectal cancer (#mCRC) in the STELLAR-303 trial. #ESMODailyReporter🔗 https://t.co/B08dNMvPhr
0
5
15
We know how important it is for #BreastCancer pts to get the right support from their HCPs Refresh your knowledge of best practices in managing breast cancer this #BreastCancerAwarenessMonth 💮 See our range of FREE #MedicalEducation programmes from world-renowned medical
0
2
0
#ESMO25: Arthur Braat discusses the use of radiopharmaceuticals in advanced gastroenteropancreatic neuroendocrine tumours (#NETs) with reference to several studies presented in Berlin. Read more in the #ESMODailyReporter👉 https://t.co/k5LuKW7iyL
#RareCancers
0
6
11
Here's the most recent #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (September 12th - September 19th, 2025). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch
1
18
55
How can we classify emetogenic risk & personalise antiemetic prophylaxis for HER2+ mBC patients receiving ADCs? 📺Oncologist Dr Sara Tolany (@stolaney1) shines a light on ADC-induced nausea+vomiting and addresses the management of other adverse events such as fatigue and ILD
0
3
8
📣 #ESMOImmuno25: Inge Marie Svane, Scientific Co-Chair, invites you submit your data for a rich exchange of ideas and cross-pollination of innovation. ⏰ Deadline: 30 September 2025 🔗 https://t.co/IYWruJxERY
0
4
12
Breasts are made up of tissue that doesn’t contain any muscle, so wearing a bra helps to support the breasts and give a defined shape. Find out more about bra sizing, how your bra should fit, and what type of bra might be best for you. https://t.co/BZYTIwffuo
0
3
4
📺 New case-based video on ADCs for HR+/HER2-metastatic #BreastCancer Dr Barbara Pistilli talks about: - The MoA of antibody–drug conjugates (ADCs) - ADCs currently available for HR+/HER2- mBC - Strategies for managing AEs ✅Endorsed by @WarOnCancer @BiomarkerCo @GRASPtweets &
0
1
4
How does #ESMOMCBS v2.0 reflect the evolving #oncology treatment landscape and the priorities of #PatientsWithCancer? Sjoukje Oosting shares her insights in the #ESMODailyReporter. 🔗 https://t.co/5vnJ8chukf
ESMO-MCBS v2.0 is now out. Significant enhancements in cancer therapies evaluation: > robust 🔍 understanding of score’s meaning, ➕ accuracy, fairness, utility of treatment assessments, 🪞 advances in science, clinical practice, patient input.
3
10
20
🎥 We’re excited to share the new #IMPORTANTProject video! Discover how our research is advancing care, improving patient support, and driving innovation in #BreastCancerResearch. Watch now https://t.co/XN1hOSSkPv
#HorizonEurope #DigitalHealth #ClinicalTrials #PersonalizedCare
0
2
4
🇪🇺✨ Our 4th #IMPORTANTProject Consortium Meeting took place in Madrid on May 23, hosted by @uned at the Faculty of Psychology. A day of collaboration, insights & planning the next steps in #BreastCancerResearch #HorizonEurope @IMPORTANTrial_Community
0
3
5
🤖 Struggling getting familiar with fundamental #AI and #DigitalTechnology #vocabulary in #oncology? 👉 Hover, click, and find clear definitions through the interactive word cloud in the ESMO AI & Digital Oncology Hub #AIOncology #HealthAI #ESMOAI25 🔗 https://t.co/yrtsa5uIAz
0
2
17